Glaukos (GKOS) Cash & Current Investments (2014 - 2026)
Glaukos (GKOS) posted quarterly Cash & Current Investments of $114.5 million for Q2 2026, up 13.56% year-over-year from $100.8 million in Q2 2025, and up 9.82% quarter-over-quarter from $104.2 million in Q1 2026.
Glaukos (GKOS) Cash & Current Investments (2014 - 2026) Analysis & Trends
Glaukos (GKOS) has reported Cash & Current Investments for 13 consecutive years, with $114.5 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Cash & Current Investments rose 13.56% year-over-year to $114.5 million; the TTM figure through Jun 2026 stood at $114.5 million (up 13.56% YoY), while the FY2025 annual figure was $90.8 million, down 46.46% from the prior year.
- Cash & Current Investments improved to $114.5 million in Q2 2026 per GKOS's latest filing, from $104.2 million in the prior quarter.
- Across five years, Cash & Current Investments topped out at $169.6 million in Q4 2024 and bottomed at $42.5 million in Q1 2024.
- Historically, Cash & Current Investments has averaged $100.5 million across 5 years, with a median of $101.7 million in 2022.
- On a YoY basis, Cash & Current Investments climbed as much as 168.86% in 2025 and fell as far as 46.46% in 2025.
- Glaukos' Cash & Current Investments stood at $119.5 million in 2022, then declined by 21.8% to $93.5 million in 2023, then surged by 81.48% to $169.6 million in 2024, then sank by 46.46% to $90.8 million in 2025, then grew by 26.07% to $114.5 million in 2026.
- Business Quant data shows GKOS's Cash & Current Investments at $114.5 million in Q2 2026, $104.2 million in Q1 2026, and $90.8 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn | 5.60 Bn |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn | 3.48 Bn |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn | 9.22 Bn |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn | 539.00 Mn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 4.25 Bn |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn | 1.95 Bn |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn | 2.11 Bn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 3.32 Bn |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn | 482.30 Mn |
| 10 | Glaukos | 11.03 Bn | 10.92 Bn | 151.59 Mn | 114.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 114.49 Mn |
| Mar 31, 2026 | 104.25 Mn |
| Dec 31, 2025 | 90.81 Mn |
| Sep 30, 2025 | 98.25 Mn |
| Jun 30, 2025 | 100.81 Mn |
| Mar 31, 2025 | 114.25 Mn |
| Dec 31, 2024 | 169.63 Mn |
| Sep 30, 2024 | 100.14 Mn |
| Jun 30, 2024 | 68.08 Mn |
| Mar 31, 2024 | 42.50 Mn |
| Dec 31, 2023 | 93.47 Mn |
| Sep 30, 2023 | 108.93 Mn |
| Jun 30, 2023 | 94.81 Mn |
| Mar 31, 2023 | 76.40 Mn |
| Dec 31, 2022 | 119.53 Mn |
| Sep 30, 2022 | 104.02 Mn |
| Jun 30, 2022 | 102.55 Mn |
| Mar 31, 2022 | 106.20 Mn |
| Dec 31, 2021 | 100.71 Mn |
| Sep 30, 2021 | 113.13 Mn |